The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...

Prometheus Laboratories has been a leader in IBD patient care solutions for 30 years. Our continuum of tests empowers providers to diagnose, treat and help get IBD patients into remission faster with ...

The MarketWatch News Department was not involved in the creation of this content. New Therapeutic Drug Monitoring Test for Interleukin--23 Inhibitor SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / ...

SAN DIEGO, CA / ACCESS Newswire / December 8, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces the launch of IBD Precis™, a next-generation ...

PredictrPK ® ADA addresses the unmet need for individualized optimization of adalimumab (ADA) therapy in support of sustained clinical remission and drug persistence. SAN DIEGO, CA / ACCESSWIRE / July ...

SAN DIEGO, June 15, 2021 /PRNewswire/ -- Prometheus Laboratories, Inc. ("Prometheus"), a leader in precision healthcare, announces the execution of an agreement with MultiPlan, a trusted partner to ...

SAN DIEGO, July 31, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the market launch of its proprietary new generation monitoring ...

SAN DIEGO, March 28, 2017 /PRNewswire/ -- Prometheus Laboratories Inc.—a Nestlé Health Science company—announces the launch of IBcause™, an all-in-one convenient test that evaluates a unique ...

SAN DIEGO, CA / ACCESS Newswire / July 29, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, announces the launch of PredictrPK ® VDZ and PredictrPK UST, ...

Prometheus Biosciences contends that the current treatments for inflammatory bowel disease are inadequate, taking a “one-size-fits-all approach” that doesn’t account for biologic variation. The ...